相关实验视频
Updated: Jun 9, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
在糖尿病管理中解锁实时数据访问:迈向互操作性模型
Pietro Randine1, Miriam Kopperstad Wolff2, Matthias Pocs3
1Department of Computer Science, Faculty of Science and Technology, UiT The Arctic University of Norway, Tromsø, Norway.
Journal of diabetes science and technology
|March 28, 2025
概括
实时糖尿病管理需要从连续血糖监测器等设备获取可访问的数据. 有限的公共API阻碍了创新,需要采取监管行动来改善数据共享和患者驱动的解决方案.
科学领域:
- 医疗信息学 医疗信息学
- 医疗器械技术 医疗器械技术
- 卫生法 法律 卫生法
背景情况:
- 健康数据的公开性,就像欧洲健康数据空间一样,提高了透明度.
- 糖尿病设备 (CGM,胰岛素) 的实时数据对于治疗调整至关重要.
- 这些数据的可访问性对于有效的糖尿病管理至关重要.
研究的目的:
- 探索糖尿病管理中的第三方应用程序的实时数据访问.
- 评估API在首要和次要用途安全数据检索中的作用.
- 分析开源糖尿病解决方案的法律框架和挑战.
主要方法:
- 在挪威评估了糖尿病医疗设备和软件解决方案,用于实时数据访问和API功能.
- 检查了服务条款和版权法的对开源创新的影响.
- 分析了管理糖尿病技术和开源挑战的法律框架.
主要成果:
- 确定了7个糖尿病设备和9个受监管的软件解决方案,只有一个提供公共API.
- 发现了特定供应商和开源软件之间实时数据访问和互操作性的重大差距.
- 发现DIY解决方案推动创新,但面临技术和法律障碍.
结论:
- 实时糖尿病管理面临安全,透明度和访问挑战.
- 需要进行监管干预,以实施互操作性模型,以便更好地访问数据.
- 公共可访问的API对于促进糖尿病护理的透明度,可访问性和患者驱动的创新至关重要.
相关概念视频
Issues And Trends In Healthcare Delivery System
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Integrated Healthcare System
An integrated healthcare system (IHS) is a set of organizations that provides for or arranges to provide coordinated and continuous service to a defined population. The IHS takes responsibility for that particular population's health status and outcome, both clinically and fiscally. An integrated healthcare system is a well-organized, well-coordinated, and collaborative network. The integrated delivery system is a network that connects different healthcare providers to deliver organized,...
Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

